TABLE 1.

MoCA Test and Classification Accuracies for 30 Different ADCs When Applying the Optimal Threshold of 23

	Prevalence	N0	N1	Sp	Se	NPV	PPV
1	0.216	91	25	0.912	0.76	0.933	0.704
2	0.223	94	27	0.830	0.741	0.918	0.556
3	0.283	198	78	0.909	0.91	0.963	0.798
4	0.293	256	106	0.879	0.774	0.904	0.726
5	0.298	139	59	0.921	0.712	0.883	0.792
6	0.325	129	62	0.899	0.806	0.906	0.794
7	0.330	77	38	0.844	0.711	0.855	0.692
8	0.364	49	28	1.000	0.464	0.766	1.000
9	0.369	123	72	0.675	0.889	0.912	0.615
10	0.371	107	63	0.897	0.794	0.881	0.820
11	0.373	151	90	0.775	0.744	0.836	0.663
12	0.375	70	42	0.914	0.500	0.753	0.778
13	0.429	20	15	0.600	0.867	0.857	0.619
14	0.450	105	86	0.762	0.756	0.792	0.722
15	0.465	76	66	0.829	0.909	0.913	0.822
16	0.478	93	85	0.903	0.812	0.840	0.885
17	0.543	37	44	0.919	0.500	0.607	0.880
18	0.561	43	55	1.000	0.691	0.717	1.000
19	0.620	68	111	0.882	0.847	0.779	0.922
20	0.620	30	49	0.900	0.755	0.692	0.925
21	0.622	96	158	0.740	0.816	0.710	0.838
22	0.635	38	66	0.895	0.773	0.694	0.927
23	0.733	40	110	0.950	0.791	0.623	0.978
24	0.737	31	87	0.903	0.701	0.519	0.953
25	0.762	35	112	0.771	0.902	0.711	0.927
26	0.765	43	140	0.907	0.586	0.402	0.953
27	0.821	63	288	0.889	0.781	0.471	0.970
28	0.825	7	33	1.000	0.455	0.280	1.000
29	0.849	21	118	0.810	0.669	0.304	0.952
30	0.870	49	327	0.959	0.847	0.485	0.993

N₀, N₁: sizes of the samples of patients without and with CI.

ADCs indicates Alzheimer Disease Centers; CI, cognitive impairment; MoCA, Montreal Cognitive Assessment; NPV, negative predictive value; PPV, positive predictive value; Se, sensitivity; Sp, specificity.